Skip to content
Open access

EP1347 - ECE_3043 - Phenotype of Polycystic Ovary Syndrome in women with and without obesity: comparison of clinical, hormonal, metabolic and sexual features

Aug 2026 · European Journal of Endocrinology · Vol 195 · 0 citations

TL;DR

It is found that PCOS in patients with severe obesity is characterized by an increased clinical hyperandrogenism, exacerbated by reduced SHBG levels and increased free androgen fractions as compared with patients without obesity.

Abstract

Obesity and Polycystic Ovary Syndrome (PCOS) share key pathophysiological mechanisms, including insulin resistance, hyperandrogenism and hypothalamic-pituitary-ovarian axis dysfunction. In literature, it is debated whether gonadal alterations in PCOS with and without obesity arise from distinct pathophysiological mechanisms. Some manifestations of PCOS are influenced by body mass index (BMI), but the specific ways in which obesity affects the gonadal axis remain unclear. To compare clinical, hormonal, and sexual parameters between women with PCOS and severe obesity and women with PCOS without obesity, focusing on extreme BMI categories to minimize phenotypic overlap. In this retrospective cross-sectional study we collected clinical data (age, BMI, Ferriman–Gallwey [F&G] score), hormonal parameters (LH, FSH, total testosterone, sex hormone binding globulin [SHBG], Δ4-androstenedione [D4A], dehydroepiandrosterone sulfate [DHEAS], anti-Müllerian hormone [AMH]), metabolic parameters (fasting glucose, lipid profile), and sexual function data (Female Sexual Function Index [FSFI]) from ninety-six women with PCOS and BMI ≥35 kg/m2 (G1) or ≤29.9 kg/m2 (G2). Patients were recruited from three centers (Auxologico San Luca, Careggi Hospital and Auxologico Piancavallo Hospital). Twenty-seven patients belonged to G1 and sixty-nine to G2. We found no significant difference between the two groups in terms of age, FSFI scores, LH and FSH levels, and the LH/FSH ratio. G1 showed higher F&G scores (P = .0410). Total testosterone and DHEAS levels were similar between groups, whereas SHBG was significantly lower and the free androgen index was higher in G1. D4A levels were lower in G2 (P = .0444). AMH levels were lower in G1 (P = .0106) and positively correlated with LH, D4A and the ovarian theca cell stimulation index (D4A × LH), independently of age, BMI, and HOMA index. Discussion: We found that PCOS in patients with severe obesity is characterized by an increased clinical hyperandrogenism, exacerbated by reduced SHBG levels and increased free androgen fractions as compared with patients without obesity. In patients with severe obesity, we observed lower AMH levels correlating with reduced thecal stimulation, as suggested by the D4A × LH index. These findings support the hypothesis of blunted central stimulation in women with PCOS and severe obesity, consistent with the effects of obesity observed in male functional hypogonadotropic hypogonadism. These findings seem to delineate a distinct endocrine, metabolic and reproductive clinical profile of PCOS due to severe obesity, characterized by reduced hypothalamic–pituitary stimulation, likely mediated by multiple interrelated factors.

Read PDF

Similar papers

Open access Sep 2026

The Relevance of Follicle Number and Androgens in Metabolic Alterations in Polycystic Ovary Syndrome: A Cross-Sectional Study

Background/Objectives: Polycystic Ovary Syndrome (PCOS) is characterized by reproductive and metabolic disturbances, including insulin resistance and altered ovarian morphology. The clinical manifestations of PCOS include metabolic, reproductive, and psychological issues that negatively affect quality of life, making P...

N. Cera, Joana Pinto, M. Maccarone et al. · 0 citations
Open access 2026

COMPARISON OF CLINICAL, METABOLIC AND ENDOCRINAL PARAMETERS OF OBESE AND LEAN POLYCYSTIC OVARY SYNDROME PATIENTS –CROSS-SECTIONAL ANALYTICAL STUDY

Obesity significantly worsens the clinical, metabolic, and endocrine manifestations of PMOS, particularly glucose metabolism and hyperandrogenism, so early identification and targeted weight-management strategies may helptoreduce metabolic complications and improve reproductive outcomes in women with PMOS.

Pragya Basak, Rizwana Parveen, S. Khan et al. · 0 citations
Open access Aug 2026

Metabolic and hormonal correlates of leptin, uric acid and soluble neprilysin in polycystic ovary syndrome/ Polyendocrine Metabolic Ovarian Syndrome

Polycystic ovary syndrome (PCOS) / Polyendocrine Metabolic Ovarian Syndrome (PMOS) is a complex endocrine and metabolic disorder in women of reproductive age. This study aimed to evaluate the relationship between serum leptin, uric acid and soluble neprilysin levels and metabolic and hormonal parameters in women with P...

Bayram Burak Ceviz, O. Baykan, Figen Efe Çamili et al. · 0 citations
Open access Sep 2026

Polycystic ovary syndrome, insulin resistance, and bone health in Saudi women: a cross-sectional study

The substantial metabolic burden of IR in Saudi women with PCOS and its association on hormonal profiles are highlighted, highlighting the importance of early IR identification and management to mitigate long-term health complications in PCOS.

Mai Albaik, F. McGuigan, Ahmed E. Altyar et al. · 0 citations
Open access Aug 2026

Polycystic Ovary Syndrome (PCOS) and obesity: do they increase the risk of urinary dysfunction and urinary tract infections?

HIGHLIGHTS The study demonstrates that obesity significantly increases the risk of urinary dysfunction and urinary tract infections in women with Polycystic Ovary Syndrome (PCOS). These findings highlight the importance of a multidisciplinary and holistic management approach that addresses not only reproductive and me...

Asih Anggraeni, U. Budihastuti, Eriana Melinawati et al. · 0 citations
Open access Aug 2026

Body mass index outperforms the Rotterdam criteria in defining phenotypic heterogeneity in polycystic ovary syndrome: a multicenter study from the Italian PCOS registry (PCOSOUTCOME.net)

In this multicenter cohort, Rotterdam phenotypes failed to discriminate metabolic risk, whereas BMI-based stratification proved more informative in identifying cardiometabolic complications.

A. Gambineri, S. Federici, E. Maseroli et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.